Hyperinsulinemia (HI) - Competitive Landscape

• More than 1.07 billion prevalent cases of HI are anticipated in 2023 in the 16 countries covered in the publisher's epidemiology forecast for HI.
• Only two approved therapeutic drugs are currently available for the treatment of HI, belonging to the IGF-1 agonist and ATP binding CC8 inhibitor therapy classes.
• There are only two Phase III pipeline drugs for HI, a single drug currently available in pre-registration stage and one in Phase III in the US and EU; four drugs are in Phase II development.
• The clinical trial space in HI consists of exclusively commercial sponsors, with Japan emerging as the key place for conducting trials.​
• Partnerships were the most prominent deal types ventured in the HI space in most geographies.​

Scope

• Disease Landscape
• Disease Overview
• Epidemiology Overview
• Treatment Overview
• Marketed Products Assessment
• Breakdown by Mechanism of Action, Route of Administration
• Product Profiles with Sales Forecast
• Pricing and Reimbursement Assessment
• Annual Therapy Cost
• Time to Pricing and Time to Reimbursement
• Pipeline Assessment
• Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
• Product Profiles with Sales Forecast
• Late-to-mid-stage Pipeline Drugs
• Phase Transition Success Rate and Likelihood of Approval
• Clinical Trials Assessment
• Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
• Enrolment Analytics, Site Analytics, Feasibility Analysis
• Deals Landscape
• Mergers, Acquisitions, and Strategic Alliances by Region
• Overview of Recent Deals
• Commercial Assessment
• Key Market Players
• Future Market Catalysts

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the HI market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global HI market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.